Antiviral Vaccines: Challenges and Advances

Ali H. Ellebedy, Rafi Ahmed

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations

Abstract

Vaccination is the most effective means of preventing and controlling viral infections. The eradication of smallpox and the significant progress made toward polio eradication are clear examples of the great impact of antiviral vaccines. However, viral infections remain a major public health threat and a significant cause of death. Most of the antiviral vaccines introduced over the past century were empirically developed. Poliomyelitis, measles, mumps, and rubella are examples of diseases that are now largely controlled thanks to these empirically developed vaccines. However, there is a growing list of viral pathogens against which effective vaccines are yet to be developed. Recent technological advances will potentially provide us with new platforms that could be harnessed to develop vaccines against emerging and reemerging viral pathogens.

Original languageEnglish
Title of host publicationThe Vaccine Book
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages283-310
Number of pages28
ISBN (Print)9780128021743
DOIs
StatePublished - Jul 11 2016
Externally publishedYes

Keywords

  • Antibodies
  • Antiviral vaccines
  • Cells
  • HIV
  • Immune
  • Infection
  • Pathogens

Fingerprint Dive into the research topics of 'Antiviral Vaccines: Challenges and Advances'. Together they form a unique fingerprint.

  • Cite this

    Ellebedy, A. H., & Ahmed, R. (2016). Antiviral Vaccines: Challenges and Advances. In The Vaccine Book: Second Edition (pp. 283-310). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-802174-3.00015-1